Opportunity Information: Apply for PAR 21 061
The Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed), PAR-21-061, is a National Cancer Institute (NCI) funding opportunity under the National Institutes of Health (NIH) designed to strengthen and diversify the basic cancer research workforce. The central goal is to recruit and support junior investigators and Early Stage Investigators who come from groups that are nationally underrepresented in biomedical, behavioral, clinical, and social science research fields. In practical terms, the program aims to help talented early-career researchers gain a foothold in basic cancer research by providing support for exploratory, early-stage projects that can generate preliminary data, sharpen a research direction, and position investigators to compete successfully for larger, longer-term NIH research grants later on.
This FOA also functions as a bridge for investigators who have completed their research training but may need additional time and resources to transition to independence. That bridge aspect is important because it acknowledges a common gap between finishing formal training (such as postdoctoral work) and being ready to submit a strong, full-scale research project grant application. By backing smaller, exploratory studies in basic cancer research, the R21 mechanism can help investigators demonstrate feasibility, establish a track record, and develop a compelling scientific narrative that supports the next step in their funding trajectory.
The announcement is explicitly limited to non-clinical trial research, meaning clinical trials are not allowed under this opportunity. The emphasis is on basic cancer research, with the exploratory R21 structure typically suited to high-impact ideas that may still be in relatively early development stages. The funding instrument is a grant, and the activity category is listed under Education and Health, with CFDA number 93.393, aligning it with NIH cancer-related research support programs.
Eligibility is broad across many U.S.-based organization types, reflecting NIH’s intention to reach investigators working in a wide range of institutional settings. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also highlights a set of institutional categories often associated with serving historically underrepresented populations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes eligibility for faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized entities, and U.S. territories or possessions.
At the same time, the FOA places firm limits on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible. In addition, foreign components as defined by the NIH Grants Policy Statement are not allowed. These restrictions mean applications must be fully anchored in eligible domestic organizations and cannot include foreign components as part of the proposed project structure.
Key administrative details from the source listing include the opportunity category as discretionary, a creation date of March 18, 2021, and an original closing date of November 17, 2023. The listing does not provide an award ceiling or expected number of awards in the provided fields, so applicants typically would need to consult the full FOA text and NIH guidance for budget structure, project period parameters, and any institute-specific considerations. Overall, this program is best understood as an early-career, exploratory funding pathway focused on building a more representative basic cancer research community while helping investigators generate the foundation needed for future, larger-scale grant support.Apply for PAR 21 061
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
- This funding opportunity was created on 2021-03-18.
- Applicants must submit their applications by 2023-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the name and number of this funding opportunity?
The opportunity is called the Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed). The FOA number is PAR-21-061.
2) Which agency and institute sponsor this opportunity?
This is a National Cancer Institute (NCI) funding opportunity under the National Institutes of Health (NIH).
3) What is the main purpose of this grant?
The central purpose is to strengthen and diversify the basic cancer research workforce by recruiting and supporting junior investigators and Early Stage Investigators from groups that are nationally underrepresented in biomedical, behavioral, clinical, and social science research fields.
4) What kind of projects is this program meant to support?
It supports exploratory, early-stage projects in basic cancer research that can help investigators generate preliminary data, refine a research direction, and become more competitive for larger NIH research grants in the future.
5) What does the R21 mechanism imply for the type of work proposed?
Based on the description provided, the R21 structure is intended for exploratory studies and early development-stage ideas, often where the goal is to demonstrate feasibility and build a foundation for later, larger-scale grant applications.
6) Who is the program trying to support (career stage)?
The program is aimed at junior investigators and Early Stage Investigators, particularly those transitioning toward research independence.
7) How does this FOA serve as a "bridge" to independence?
It is described as a bridge for investigators who have completed research training but need additional time and resources to transition to independence. The intent is to help close the gap between finishing formal training (such as postdoctoral work) and being ready to submit a strong, full-scale research project grant application.
8) Are clinical trials allowed under this opportunity?
No. The announcement is explicitly limited to non-clinical trial research. Clinical trials are not allowed.
9) What research area does this funding focus on?
The emphasis is on basic cancer research.
10) What is the funding instrument type?
The funding instrument is a grant.
11) How is the activity category described in the listing?
The activity category is listed under Education and Health.
12) What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.393.
13) What types of U.S. organizations are eligible to apply?
Eligibility is broad and includes many U.S.-based organization types, including:
- State, county, city or township, and special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Tribal organizations other than federally recognized tribal governments
- Public housing authorities/Indian housing authorities
- Nonprofits with 501(c)(3) status (excluding institutions of higher education in those nonprofit categories)
- Nonprofits without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories)
- For-profit organizations other than small businesses
- Small businesses
- Other eligible entities
- Faith-based or community-based organizations
- Eligible federal agencies
- Regional organizations
- U.S. territories or possessions
14) Are minority-serving institutions specifically mentioned as eligible or relevant?
Yes. The FOA highlights categories often associated with serving historically underrepresented populations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
15) Are non-U.S. (foreign) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
16) Can a U.S. organization include a non-domestic component in its application?
No. Non-domestic components of U.S. organizations are not eligible.
17) Are foreign components allowed in any form?
No. Foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
18) What do the foreign involvement restrictions mean in practical terms?
The application must be fully anchored in eligible domestic organizations and cannot include foreign components as part of the proposed project structure.
19) What is the opportunity category?
The opportunity category is listed as discretionary.
20) When was this opportunity created?
The creation date listed is March 18, 2021.
21) What was the original closing date shown in the listing?
The original closing date listed is November 17, 2023.
22) Does the provided listing specify an award ceiling?
No. The provided fields do not include an award ceiling.
23) Does the provided listing specify the expected number of awards?
No. The provided fields do not include the expected number of awards.
24) Where should applicants look for budget structure or project period details?
Because those details are not provided in the listing fields shared here, applicants would typically need to consult the full FOA text and NIH guidance for budget structure, project period parameters, and any institute-specific considerations.
25) What is the big-picture benefit this award is intended to provide to early-career investigators?
It is intended to help early-career researchers gain a foothold in basic cancer research by supporting exploratory studies that build feasibility, preliminary data, and a track record, positioning them to compete successfully for larger, longer-term NIH research grants later on.
Browse more opportunities from the same category: Education, Health
Next opportunity: Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)
Previous opportunity: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 061
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 061) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) Apply for PAR 21 183 Funding Number: PAR 21 183 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 21 036 Funding Number: RFA CA 21 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed) Apply for RFA LM 21 001 Funding Number: RFA LM 21 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Apply for PAR 21 206 Funding Number: PAR 21 206 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,000 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) Apply for PAR 21 166 Funding Number: PAR 21 166 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,000 |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Apply for PAR 21 208 Funding Number: PAR 21 208 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional) Apply for RFA AI 21 023 Funding Number: RFA AI 21 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 025 Funding Number: RFA AI 21 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 024 Funding Number: RFA AI 21 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Apply for RFA DA 22 002 Funding Number: RFA DA 22 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) Apply for PAR 21 213 Funding Number: PAR 21 213 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed) Apply for RFA DA 22 019 Funding Number: RFA DA 22 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 22 021 Funding Number: RFA DA 22 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) Apply for RFA CA 21 029 Funding Number: RFA CA 21 029 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) Apply for RFA DA 22 001 Funding Number: RFA DA 22 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) Apply for RFA CA 21 031 Funding Number: RFA CA 21 031 Agency: National Institutes of Health Category: Education, Health Funding Amount: $875,000 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) Apply for PA 21 180 Funding Number: PA 21 180 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) Apply for RFA DA 22 007 Funding Number: RFA DA 22 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) Apply for RFA DA 22 005 Funding Number: RFA DA 22 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 22 024 Funding Number: RFA DA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 061", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
